Skip to main content

Terrestrial Bio

Cambridge, United States

Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.

$50.0M raised
Mar 2026
Series C

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Terrestrial Bio

How much funding has Terrestrial Bio raised?
Terrestrial Bio has raised $50.0M in total funding. The most recent round was Series C. The last funding was announced in March 2026.
Who are Terrestrial Bio's investors?
Terrestrial Bio's investors include RA Capital Management, Bill & Melinda Gates Foundation, National Science Foundation, Engine Ventures, Verizon.
Where is Terrestrial Bio headquartered?
Terrestrial Bio is headquartered in Cambridge, United States.
What does Terrestrial Bio do?
Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.
What stage is Terrestrial Bio at?
Terrestrial Bio is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Terrestrial Bio — Funding & Investors." VCBacked, March 26, 2026, https://www.vcbacked.co/company/terrestrial-bio. Accessed July 8, 2026.
APA
VCBacked. (2026). Terrestrial Bio — Funding & Investors. Retrieved July 8, 2026, from https://www.vcbacked.co/company/terrestrial-bio
Wikipedia (cite web)
{{cite web |title=Terrestrial Bio — Funding & Investors |url=https://www.vcbacked.co/company/terrestrial-bio |website=VCBacked |access-date=July 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .